Ahren Innovation Capital Archives

OutSee Raises £2.5M Seed and Partners With o2h Discovery to Advance AI-Driven Drug Target Development

OutSee, a genomics and drug discovery company developing an AI-based predictive genomics platform, has closed a £2.5 million seed funding round and signed a strategic collaboration with o2h discovery, a preclinical contract research organisation.

14 Jan 2026 · 1 min read

Ahren Innovation Capital

OutSee Raises £2.5M Seed and Partners With o2h Discovery to Advance AI-Driven Drug Target Development

Trending today

Augmeta Secures $3M Seed to Assign AI Operators to Every Business KPI

Menos AI Surpasses $10M in Total Funding as Copper Sky Capital Doubles Down

The Week Ahead in AI: Trump Appoints AI Czar, Forms ‘Super Intelligence Force’, Musk to Rename SpaceXAI, Report of New Open Model, Plus Earnings & Events

America.gov AI Chatbot Hides a Minecraft Easter Egg Inspired by the Game’s End Poem

Agility Robotics CEO Peggy Johnson Joins DOW-Commissioned Project Meridian

Ahren Innovation Capital

OutSee Raises £2.5M Seed and Partners With o2h Discovery to Advance AI-Driven Drug Target Development

Trending today

Augmeta Secures $3M Seed to Assign AI Operators to Every Business KPI

Menos AI Surpasses $10M in Total Funding as Copper Sky Capital Doubles Down

The Week Ahead in AI: Trump Appoints AI Czar, Forms ‘Super Intelligence Force’, Musk to Rename SpaceXAI, Report of New Open Model, Plus Earnings & Events

America.gov AI Chatbot Hides a Minecraft Easter Egg Inspired by the Game’s End Poem

Agility Robotics CEO Peggy Johnson Joins DOW-Commissioned Project Meridian

The AI economy, every weekday morning